<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ep-patent-document PUBLIC "-//EPO//EP PATENT DOCUMENT 1.5//EN" "ep-patent-document-v1-5.dtd">
<ep-patent-document id="EP09707226B8W1" file="EP09707226W1B8.xml" lang="en" country="EP" doc-number="2249860" kind="B8" correction-code="W1" date-publ="20151118" status="c" dtd-version="ep-patent-document-v1-5">
<SDOBI lang="en"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSKBAHRIS..MTNORS......................</B001EP><B003EP>*</B003EP><B005EP>J</B005EP><B007EP>JDIM360 Ver 1.28 (29 Oct 2014) -  2999001/0</B007EP></eptags></B000><B100><B110>2249860</B110><B120><B121>CORRECTED EUROPEAN PATENT SPECIFICATION</B121></B120><B130>B8</B130><B132EP>B1</B132EP><B140><date>20151118</date></B140><B150><B151>W1</B151><B153>73</B153><B155><B1551>de</B1551><B1552>Bibliographie</B1552><B1551>en</B1551><B1552>Bibliography</B1552><B1551>fr</B1551><B1552>Bibliographie</B1552></B155></B150><B190>EP</B190></B100><B200><B210>09707226.8</B210><B220><date>20090205</date></B220><B240><B241><date>20100903</date></B241></B240><B250>en</B250><B251EP>en</B251EP><B260>en</B260></B200><B300><B310>PCT/IB2008/000292</B310><B320><date>20080208</date></B320><B330><ctry>WO</ctry></B330></B300><B400><B405><date>20151118</date><bnum>201547</bnum></B405><B430><date>20101117</date><bnum>201046</bnum></B430><B450><date>20151014</date><bnum>201542</bnum></B450><B452EP><date>20150508</date></B452EP><B480><date>20151118</date><bnum>201547</bnum></B480></B400><B500><B510EP><classification-ipcr sequence="1"><text>A61K  38/13        20060101AFI20090827BHEP        </text></classification-ipcr><classification-ipcr sequence="2"><text>A61P  21/00        20060101ALI20090827BHEP        </text></classification-ipcr></B510EP><B540><B541>de</B541><B542>NICHT IMMUNSUPPRESSIVES CYCLOSPORIN ZUR BEHANDLUNG VON GLIEDERGÜRTEL-MUSKELDYSTROPHIE</B542><B541>en</B541><B542>NON-IMMUNOSUPPRESSIVE CYCLOSPORIN FOR THE TREATMENT OF LIMB-GIRDLE MUSCULAR DYSTROPHY</B542><B541>fr</B541><B542>CYCLOSPORINE NON IMMUNOSUPPRESSIVE POUR LE TRAITEMENT DE LA DYSTROPHIE MUSCULAIRE DES CEINTURES</B542></B540><B560><B561><text>WO-A-2006/072639</text></B561><B562><text>ANGELIN A ET AL: "Mitochondrial dysfunction in the pathogenesis of Ullrich congenital muscular dystrophy and prospective therapy with cyclosporins" PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 20070116 US, vol. 104, no. 3, 16 January 2007 (2007-01-16), pages 991-996, XP002504969 ISSN: 0027-8424</text></B562><B562><text>EMERY A E: "The muscular dystrophies" LANCET THE, LANCET LIMITED. LONDON, GB, vol. 359, no. 9307, 23 February 2002 (2002-02-23), pages 687-695, XP004790771 ISSN: 0140-6736</text></B562><B562><text>MAGNUS J HANSSON ET AL: "The Nonimmunosuppressive Cyclosporin Analogs NIM811 and UNIL025 Display Nanomolar Potencies on Permeability Transition in Brain-Derived Mitochondria" JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, KLUWER ACADEMIC PUBLISHERS-PLENUM PUBLISHERS, NE, vol. 36, no. 4, 1 August 2004 (2004-08-01) , pages 407-413, XP019280564 ISSN: 1573-6881</text></B562><B562><text>PARSONS STEPHANIE A ET AL: "Genetic disruption of calcineurin improves skeletal muscle pathology and cardiac disease in a mouse model of limb-girdle muscular dystrophy." THE JOURNAL OF BIOLOGICAL CHEMISTRY 30 MAR 2007, vol. 282, no. 13, 30 March 2007 (2007-03-30), pages 10068-10078, XP002504970 ISSN: 0021-9258 cited in the application</text></B562><B562><text>DANIELE ET AL: "Ins and outs of therapy in limb girdle muscular dystrophies" INTERNATIONAL JOURNAL OF BIOCHEMISTRY AND CELL BIOLOGY, EXETER, GB, vol. 39, no. 9, 1 January 2007 (2007-01-01), pages 1608-1624, XP022168756 ISSN: 1357-2725</text></B562><B562><text>NAKAYAMA HIROYUKI ET AL: "Ca2+- and mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failure." THE JOURNAL OF CLINICAL INVESTIGATION SEP 2007, vol. 117, no. 9, September 2007 (2007-09), pages 2431-2444, XP002572910 ISSN: 0021-9738</text></B562><B562><text>MILLAY DOUGLAS P ET AL: "Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy." NATURE MEDICINE APR 2008, vol. 14, no. 4, April 2008 (2008-04), pages 442-447, XP002572911 ISSN: 1546-170X</text></B562><B562><text>REUTENAUER J ET AL: "Investigation of Debio 025, a cyclophilin inhibitor, in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy." BRITISH JOURNAL OF PHARMACOLOGY OCT 2008, vol. 155, no. 4, October 2008 (2008-10), pages 574-584, XP002572912 ISSN: 0007-1188</text></B562></B560></B500><B700><B720><B721><snm>MOLKENTIN, Jeffery, D.</snm><adr><str>5756 Babygold Ct</str><city>Cincinnati
OH 45247</city><ctry>US</ctry></adr></B721></B720><B730><B731><snm>Debiopharm International SA</snm><iid>101548363</iid><irf>P2160EP00</irf><adr><str>Forum "après-demain" 
Chemin Messidor 5-7</str><city>1002 Lausanne</city><ctry>CH</ctry></adr></B731></B730><B740><B741><snm>Grosfillier, Philippe</snm><iid>101292212</iid><adr><str>ANDRE ROLAND SA 
Chemin des Charmettes 9 
P.O. Box 5107</str><city>1002 Lausanne</city><ctry>CH</ctry></adr></B741></B740></B700><B800><B840><ctry>AT</ctry><ctry>BE</ctry><ctry>BG</ctry><ctry>CH</ctry><ctry>CY</ctry><ctry>CZ</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>EE</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>HR</ctry><ctry>HU</ctry><ctry>IE</ctry><ctry>IS</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LT</ctry><ctry>LU</ctry><ctry>LV</ctry><ctry>MC</ctry><ctry>MK</ctry><ctry>MT</ctry><ctry>NL</ctry><ctry>NO</ctry><ctry>PL</ctry><ctry>PT</ctry><ctry>RO</ctry><ctry>SE</ctry><ctry>SI</ctry><ctry>SK</ctry><ctry>TR</ctry></B840><B844EP><B845EP><ctry>AL</ctry><date>20100903</date></B845EP><B845EP><ctry>BA</ctry><date>20100903</date></B845EP><B845EP><ctry>RS</ctry><date>20100903</date></B845EP></B844EP><B860><B861><dnum><anum>IB2009000204</anum></dnum><date>20090205</date></B861><B862>en</B862></B860><B870><B871><dnum><pnum>WO2009098577</pnum></dnum><date>20090813</date><bnum>200933</bnum></B871></B870></B800></SDOBI>
</ep-patent-document>
